OXSORALEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Oxsoralen, and what generic alternatives are available?
Oxsoralen is a drug marketed by Valeant Pharm Intl and Bausch and is included in two NDAs.
The generic ingredient in OXSORALEN is methoxsalen. There are seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methoxsalen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxsoralen
A generic version of OXSORALEN was approved as methoxsalen by STRIDES PHARMA on June 5th, 2014.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OXSORALEN?
- What are the global sales for OXSORALEN?
- What is Average Wholesale Price for OXSORALEN?
Summary for OXSORALEN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 150 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,098 |
| DailyMed Link: | OXSORALEN at DailyMed |
Recent Clinical Trials for OXSORALEN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Phase 1 |
| National Cancer Institute (NCI) | Phase 1 |
US Patents and Regulatory Information for OXSORALEN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valeant Pharm Intl | OXSORALEN | methoxsalen | LOTION;TOPICAL | 009048-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch | OXSORALEN-ULTRA | methoxsalen | CAPSULE;ORAL | 019600-001 | Oct 30, 1986 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
